PLEASANTON, California–(BUSINESS WIRE)–OPM Biosciences, una empresa dedicada a los medios de cultivo celular y a las soluciones para bioprocesos, ha anunciado hoy dos nuevas ofertas que amplían su plataforma OPM-CHO™ al ámbito del desarrollo y la fabricación de biosimilares: el Biosimilar Media Optimization Service y la Sureness™ Biosimilar Platform. Los medios de cultivo cellular influyen significativamente en el crecimiento, la productividad y los atributos criticos de calidad, haciendo que
Author: sHq_LoGiNz
PLEASANTON, California–(BUSINESS WIRE)–OPM Biosciences, una empresa dedicada a los medios de cultivo celular y a las soluciones para bioprocesos, ha anunciado hoy dos nuevas ofertas que amplían su plataforma OPM-CHO™ al ámbito del desarrollo y la fabricación de biosimilares: el Biosimilar Media Optimization Service y la Sureness™ Biosimilar Platform. Los medios de cultivo cellular influyen significativamente en el crecimiento, la productividad y los atributos criticos de calidad, haciendo que
PLEASANTON, Californie–(BUSINESS WIRE)–OPM Biosciences, société spécialisée dans les milieux de culture cellulaire et les solutions de bioprocédés, a annoncé aujourd’hui le lancement de deux nouvelles offres qui étendent sa plateforme OPM-CHO™ au développement et à la fabrication de médicaments biosimilaires : le Biosimilar Media Optimization Service et la Sureness™ Biosimilar Platform. Les milieux de culture cellulaire peuvent influencer de manière significative la croissance cellulaire, la
PLEASANTON, Californie–(BUSINESS WIRE)–OPM Biosciences, société spécialisée dans les milieux de culture cellulaire et les solutions de bioprocédés, a annoncé aujourd’hui le lancement de deux nouvelles offres qui étendent sa plateforme OPM-CHO™ au développement et à la fabrication de médicaments biosimilaires : le Biosimilar Media Optimization Service et la Sureness™ Biosimilar Platform. Les milieux de culture cellulaire peuvent influencer de manière significative la croissance cellulaire, la
PLEASANTON, Calif.–(BUSINESS WIRE)–OPM Biosciences, azienda fornitrice di terreni di coltura e soluzioni per i bioprocessi, oggi ha annunciato due nuove offerte che estendono la sua piattaforma OPM-CHO™ nello sviluppo e nella produzione di farmaci biosimilari: Biosimilar Media Optimization Service (Servizio di ottimizzazione dei terreni di coltura per biosimilari) e Sureness™ Biosimilar Platform (Piattaforma per biosimilari). I terreni di coltura cellulare possono influire significativamente
PLEASANTON, Calif.–(BUSINESS WIRE)–OPM Biosciences, azienda fornitrice di terreni di coltura e soluzioni per i bioprocessi, oggi ha annunciato due nuove offerte che estendono la sua piattaforma OPM-CHO™ nello sviluppo e nella produzione di farmaci biosimilari: Biosimilar Media Optimization Service (Servizio di ottimizzazione dei terreni di coltura per biosimilari) e Sureness™ Biosimilar Platform (Piattaforma per biosimilari). I terreni di coltura cellulare possono influire significativamente
SHANGHAI–(BUSINESS WIRE)– #AI–Robbyant, an embodied AI company within Ant Group, and the Arab Federation for Digital Economy (AFDE) today announced the signing of a Memorandum of Understanding (MoU) to advance the deployment, localization and commercialization of embodied AI and robotic solutions in the United Arab Emirates and the wider GCC (Gulf Cooperation Council) and Middle East markets. The agreement was signed by Dr. Ayman Ghoneim, Assistant Secretary-General of AFDE, and Yu Liang, Head of
SHANGHAI–(BUSINESS WIRE)– #AI–Robbyant, an embodied AI company within Ant Group, and the Arab Federation for Digital Economy (AFDE) today announced the signing of a Memorandum of Understanding (MoU) to advance the deployment, localization and commercialization of embodied AI and robotic solutions in the United Arab Emirates and the wider GCC (Gulf Cooperation Council) and Middle East markets. The agreement was signed by Dr. Ayman Ghoneim, Assistant Secretary-General of AFDE, and Yu Liang, Head of
SHANGHAI–(BUSINESS WIRE)– #AI–Robbyant, an embodied AI company within Ant Group, and the Arab Federation for Digital Economy (AFDE) today announced the signing of a Memorandum of Understanding (MoU) to advance the deployment, localization and commercialization of embodied AI and robotic solutions in the United Arab Emirates and the wider GCC (Gulf Cooperation Council) and Middle East markets. The agreement was signed by Dr. Ayman Ghoneim, Assistant Secretary-General of AFDE, and Yu Liang, Head of
MCLEAN, Va.–(BUSINESS WIRE)–Next year, travelers are expected to ditch perfection for personal growth, flexibility and discovery. According to Hilton’s newly released 2027 Trends Report, The Great Rebalance: How Travelers Are Expecting to Reset and Recalibrate in 2027, jetsetters are prioritizing trips that help them reset, gain perspective and make the most of their time away. “We’re seeing that travelers are less interested in someone else’s definition of perfection and more focused on plan
